Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frank Stephen Hodi, M.D.

Concepts (735)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma2032024550514.360 Why?
Antibodies, Monoclonal99202392595.510 Why?
Skin Neoplasms80202356855.110 Why?
Immunotherapy68202344444.060 Why?
Antineoplastic Combined Chemotherapy Protocols592023114993.320 Why?
Antineoplastic Agents642023136472.640 Why?
Cancer Vaccines25202310392.630 Why?
Granulocyte-Macrophage Colony-Stimulating Factor1720239002.540 Why?
Neoplasms682023216702.060 Why?
Uveal Neoplasms720203101.910 Why?
Mucous Membrane920216731.690 Why?
Proto-Oncogene Proteins B-raf24202120261.670 Why?
Proto-Oncogene Proteins c-kit920177771.670 Why?
Lymphocytes, Tumor-Infiltrating18202010411.480 Why?
CD8-Positive T-Lymphocytes19202144791.320 Why?
Tumor Microenvironment20202335661.240 Why?
Indoles11201918351.230 Why?
Vascular Endothelial Growth Factor A9202435031.210 Why?
Immunomodulation520195431.180 Why?
Carcinoma, Non-Small-Cell Lung20202352331.070 Why?
Antigens, CD13202240251.060 Why?
Oncolytic Viruses320213271.040 Why?
Mutation382023297011.000 Why?
Pneumonia8202121391.000 Why?
Pyrimidines6201729370.990 Why?
Humans33720247435210.960 Why?
Neoplasm Metastasis30202248400.960 Why?
HSP90 Heat-Shock Proteins220184320.890 Why?
T-Lymphocytes, Cytotoxic7201918260.860 Why?
Lung Neoplasms262023131050.860 Why?
Receptors, Vascular Endothelial Growth Factor220246640.840 Why?
Neoplasm Staging452022110180.840 Why?
Carcinoma, Renal Cell14202031330.820 Why?
Middle Aged14920232131850.810 Why?
Aged13220221631370.810 Why?
Disease-Free Survival28201968810.760 Why?
Brain Neoplasms18202188100.750 Why?
Triazoles220189030.730 Why?
Aged, 80 and over672022577390.730 Why?
Protein Kinase C3202012280.710 Why?
Kaplan-Meier Estimate26201965350.710 Why?
Antibodies, Neoplasm420162860.710 Why?
Pyrroles3202011430.700 Why?
Oncolytic Virotherapy420224970.700 Why?
Treatment Outcome702021631050.700 Why?
X-Linked Inhibitor of Apoptosis Protein12019620.680 Why?
Antigens, Differentiation420089270.680 Why?
Drug Resistance, Neoplasm12202151500.680 Why?
Protein Kinase Inhibitors14201955060.650 Why?
Male15920233497710.650 Why?
CD4-Positive T-Lymphocytes5202043810.640 Why?
Female16720233798750.640 Why?
Granuloma220183190.630 Why?
Gene Expression Regulation, Neoplastic15202184050.630 Why?
Vacuolar Proton-Translocating ATPases220141950.630 Why?
Sarcoidosis, Pulmonary12018440.620 Why?
Antibodies, Blocking420192540.610 Why?
Clinical Trials as Topic22202379010.600 Why?
Lymphoma5202218820.600 Why?
Antigens, Neoplasm14202119940.590 Why?
Piperazines4201424810.580 Why?
Angiopoietin-2220161710.560 Why?
Adult10720232138700.550 Why?
Molecular Targeted Therapy14202127110.550 Why?
Galectin 1120171290.550 Why?
Colitis7202211740.540 Why?
Leukocytes, Mononuclear10202418390.540 Why?
Herpesvirus 1, Human320227420.530 Why?
Histone Deacetylase Inhibitors220217870.530 Why?
Drug Administration Schedule17202149280.520 Why?
Epitopes, T-Lymphocyte120198800.510 Why?
Recombinant Fusion Proteins1202437590.510 Why?
Sulfonamides7201419290.500 Why?
GTP-Binding Protein alpha Subunits220121000.500 Why?
Mitogen-Activated Protein Kinase Kinases420216460.490 Why?
Benzamides4201413820.490 Why?
Solitary Pulmonary Nodule120182630.490 Why?
Combined Modality Therapy13202286320.480 Why?
Neovascularization, Pathologic5201926330.480 Why?
Killer Cells, Natural4202321350.480 Why?
Kidney Neoplasms10202042430.460 Why?
Survival Rate222021127760.460 Why?
Hydroxamic Acids120164940.460 Why?
HLA Antigens2201813690.450 Why?
Drug Synergism3201617900.450 Why?
MAP Kinase Kinase Kinases520192610.450 Why?
Disease Progression232022132490.450 Why?
Clinical Trials, Phase II as Topic820196270.450 Why?
T-Lymphocytes152023101770.440 Why?
Inhibitor of Apoptosis Proteins420162140.440 Why?
Radiotherapy2201915290.430 Why?
Prognosis292021290000.420 Why?
Cell Line, Tumor232020166180.410 Why?
T-Lymphocytes, Regulatory9202029870.410 Why?
Immunity, Humoral520195950.410 Why?
Ovarian Neoplasms5202048350.400 Why?
Immunity, Cellular3201616100.400 Why?
Sunlight120133230.390 Why?
Neoplasm Proteins8202137060.390 Why?
Dose-Response Relationship, Drug192021109250.390 Why?
Hepatitis320232260.380 Why?
Immunophenotyping7202218720.380 Why?
Thyroid Diseases320193800.380 Why?
Cell Proliferation92021104550.380 Why?
Quinazolines2202013530.370 Why?
Cytokines11202273330.350 Why?
Melanoma, Experimental420195600.340 Why?
Peptide Fragments3201950910.340 Why?
Apoptosis8202196930.330 Why?
Medical Oncology4202322670.330 Why?
T-Lymphocyte Subsets6201918340.330 Why?
Tumor Burden8202219080.330 Why?
Gene Amplification1201310640.330 Why?
Antibody Formation5201614040.320 Why?
Tumor Escape320213450.320 Why?
Maximum Tolerated Dose1020228910.310 Why?
Imidazoles6201912060.310 Why?
Survival Analysis152020102390.310 Why?
Proto-Oncogene Proteins c-met120125720.310 Why?
MAP Kinase Signaling System2201215200.310 Why?
Double-Blind Method112022120210.300 Why?
Diagnostic Imaging2201834790.300 Why?
Hematopoietic Stem Cell Transplantation6202353990.280 Why?
Autoimmunity3201813560.280 Why?
Tomography, X-Ray Computed142019201300.280 Why?
Adrenal Cortex Hormones5202118510.280 Why?
Extracellular Signal-Regulated MAP Kinases420136200.280 Why?
Amino Acid Sequence42021137980.270 Why?
Hematologic Neoplasms2201618220.270 Why?
Tumor Cells, Cultured9202162930.270 Why?
Follow-Up Studies212021390470.270 Why?
Clinical Trials, Phase III as Topic720188410.270 Why?
Oximes420193090.270 Why?
Endocrine System Diseases220182490.260 Why?
Adjuvants, Immunologic3202210410.260 Why?
Immunization, Passive120086220.260 Why?
Cell Adhesion Molecules2202316010.260 Why?
Gene Expression Profiling13202194070.240 Why?
Phosphatidylinositol 3-Kinases2202229260.240 Why?
Neoplasm Recurrence, Local10202292360.240 Why?
North America2202112490.240 Why?
Rectal Neoplasms2201611850.240 Why?
Insulin-Like Growth Factor I1201220180.230 Why?
Autoantigens120089010.230 Why?
Immunologic Factors3202115720.230 Why?
Young Adult252021564100.230 Why?
Animals4620221684340.230 Why?
Cytotoxicity, Immunologic2202313690.230 Why?
NF-kappa B1201224900.230 Why?
Immunohistochemistry122019113530.230 Why?
Hypothyroidism320196590.220 Why?
Immunosuppressive Agents4202140940.220 Why?
Dose-Response Relationship, Immunologic220213730.220 Why?
Adaptor Proteins, Signal Transducing2201129140.220 Why?